Podcasts about gastric

In this episode, we detail the pathophysiology of intestinal methanogen overgrowth (IMO), hydrogen-dominant small intestinal bacterial overgrowth (H₂-SIBO), and hydrogen sulfide-dominant SIBO (H₂S-SIBO), discussing their mechanistic interactions and overlap. We discuss methanogenic archaea, as well hydrogen sulfide- and hydrogen-producing microbes and their contributions to altered gastrointestinal motility, epithelial barrier function, and neuromuscular signaling. We detail host endogenous defense mechanisms, including gastric acid secretion, pancreatic enzymatic activity, bile flow, intestinal motility, and more.Topics:1. Introduction- Overview of intestinal methanogen overgrowth (IMO), hydrogen sulfide-dominant SIBO, and hydrogen-dominant SIBO  - Discussion of overlap  2. Intestinal Methanogen Overgrowth (IMO)- Characterized by an overabundance of methane-producing archaea  - Methane and intestinal transit- Bloating, abdominal discomfort, constipation  - Associated with irritable bowel syndrome with constipation (IBS-C)   3. Overlap Between IMO and SIBO Subtypes- Hydrogen as a substrate for methane and/or hydrogen sulfide production- Shared potential root causes 4. Small Intestinal Bacterial Overgrowth (SIBO) and Protective Mechanisms- The small intestine remains relatively free of bacteria due to protective mechanisms  - Gastric acid secretion - Pancreatic enzymes and bile - Intestinal motility- Structural abnormalities 5. Hydrogen-Dominant SIBO - Increased hydrogen and intestinal transit- Potential symptoms, diarrhea, postprandial bloating  - Different forms of SIBO can coexist  6. Hydrogen Sulfide-Dominant SIBO - H₂S and intestinal motility- H₂S and intestinal epithelial integrity- Symptoms, associations with IBS diarrhea    7. Host Defense Mechanisms Regulating Microbial Balance- Gastric acid secretion, pancreatic enzyme activity, bile flow, intestinal motility, and more 8. Gastric Acid and Its Role in Microbial Regulation- Parietal cells secrete hydrochloric acid (HCl) and intrinsic factor  - Chief cells secrete pepsinogen, conversion into pepsin in acidic conditions  - Gastric acid, digestion and antimicrobial defense   9. Hypochlorhydria - Low gastric acid impairs microbial defense- Reduced acidity disrupts digestion and downstream pancreatic enzyme and bile release   10. Pancreatic Enzymes and Their Role in Microbial Regulation- Pancreatic enzymes, digestion, antimicrobial activity - Enzymes modify chyme to limit fermentable substrates that fuel microbial proliferation   11. Intestinal Motility - Coordinated contractions propel food, microbes, and waste through the GI tract  - The enteric nervous system (ENS) and gut motility- The myenteric plexus controls peristalsis, while the submucosal plexus regulates secretion and absorption   12. Conclusion- Intestinal methanogen overgrowth (IMO), hydrogen-dominant SIBO, and hydrogen sulfide-dominant SIBO - Overlap in symptoms and microbial interactions  - Host defense mechanisms, including gastric acid, pancreatic enzymes, and motility  - Intestinal motility and ENS function in microbial homeostasis  - Hydrogen sulfide as a gasotransmitterThank you to our episode sponsors:1. Shop ⁠⁠⁠⁠⁠Fresh Press Farms⁠⁠⁠'⁠⁠⁠⁠Peach Cider Vinegar⁠⁠ at Sprouts locations nationwide, and check out their full collection ⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠. 2. Shop ⁠CYLN's⁠ full skincare line ⁠here⁠.Get Chloe's Book Today! "⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠75 Gut-Healing Strategies & Biohacks⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠" Follow Chloe on Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@synthesisofwellness⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠synthesisofwellness.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

In this episode of the Becker's Healthcare Podcast, host Lukas Voss explores cutting-edge advancements in gastric and esophageal cancer care with two leading experts from City of Hope. Surgical Oncologist Dr. Yanghee Woo and Medical Oncologist Dr. Dani Castillo discuss the benefits of a multidisciplinary approach, the impact of robotic-assisted minimally invasive surgery, and the latest clinical trials offering new hope for patients.This episode is sponsored by City of Hope.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ZSW865. CME/MOC/AAPA/IPCE credit will be available until February 10, 2026.Establishing the Pillars for Precision Care in Gastric/GEJ Cancer: Expert Guidance on Integrating Molecular Screening and Immunotherapy Platforms Across the Disease Continuum In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ZSW865. CME/MOC/AAPA/IPCE credit will be available until February 10, 2026.Establishing the Pillars for Precision Care in Gastric/GEJ Cancer: Expert Guidance on Integrating Molecular Screening and Immunotherapy Platforms Across the Disease Continuum In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ZSW865. CME/MOC/AAPA/IPCE credit will be available until February 10, 2026.Establishing the Pillars for Precision Care in Gastric/GEJ Cancer: Expert Guidance on Integrating Molecular Screening and Immunotherapy Platforms Across the Disease Continuum In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ZSW865. CME/MOC/AAPA/IPCE credit will be available until February 10, 2026.Establishing the Pillars for Precision Care in Gastric/GEJ Cancer: Expert Guidance on Integrating Molecular Screening and Immunotherapy Platforms Across the Disease Continuum In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ZSW865. CME/MOC/AAPA/IPCE credit will be available until February 10, 2026.Establishing the Pillars for Precision Care in Gastric/GEJ Cancer: Expert Guidance on Integrating Molecular Screening and Immunotherapy Platforms Across the Disease Continuum In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ZSW865. CME/MOC/AAPA/IPCE credit will be available until February 10, 2026.Establishing the Pillars for Precision Care in Gastric/GEJ Cancer: Expert Guidance on Integrating Molecular Screening and Immunotherapy Platforms Across the Disease Continuum In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

Carla Piera FitzGerald lost half her body weight in 14 months – An incredible loss of 13 stone or 83 kilos. She told us about her unhealthy relationship with food which began with hiding sweets aged 5 and continued through to her 30s. She tried every diet going but it was only when Carla sorted her head out, that she began to see substantial changes in her body.Carla's story is so inspiring, especially for anyone looking for a fresh start this January, and it just goes to show what we can do when we're consistent and when we put our minds to something. Carla spoke openly about Ozempic and Gastric bands which are seen as ‘quick and easy' fixes, and she shared all the unexpected ways weight loss has improved her life from making flying easier, to making her taller!Carla's new podcast The Imperfectionist is out now!

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Vivek Kaul, MD The American Society for Gastrointestinal Endoscopy (ASGE) recently released a new guideline on when to use endoscopic submucosal dissection (ESD) and endoscopic mucosal resection (EMR) in managing early esophageal and gastric cancers. To learn more about when to use each approach, Dr. Peter Buch sits down with guideline co-author Dr. Vivek Kaul. Dr. Kaul is also the Segal-Watson Professor of Medicine at the University of Rochester Medical Center in New York.

In this episode of SurgOnc Today®, Steve Kwon, MD, and Mike Mavros, MD, are joined by Joo Ha Hwang, MD, and Yanghee Woo, MD, for a discussion of managing patients at high-risk of gastric cancer development at the population-level and at the patient-level. The panel will also discuss nonoperative and operative strategies in managing precancerous gastric lesions and early gastric cancers.

In this episode, we discuss the anatomy and physiology of the stomach and its unique epithelial structure. We dive into the pathophysiological implications of conditions such as Helicobacter pylori infection and hypochlorhydria, examining how they disrupt gastric function and microbial balance. Finally, we connect these concepts to the small intestine, discussing possible downstream effects of altered gastric acid secretion, focusing on microbial colonization and contributions to broader gastrointestinal health challenges, such as small intestinal bacterial overgrowth (SIBO). Topics: 1. Introduction Highlighting the stomach and anatomy. Discussion on H. pylori. Interplay between the stomach and small intestines, focusing on microbial balance and overgrowth. 2. Anatomy of the Stomach The stomach as a hollow, muscular organ located between the esophagus and small intestine. Anatomical regions: cardia, fundus, body, and pylorus. Layers of gastric mucosa: epithelial lining, lamina propria, and thin band of smooth muscle. 3. Epithelial Lining and Specialized Cells Mucous cells: Location within the surface epithelium and gastric pits. Secretion of viscous mucus containing mucins, forming a protective barrier. Role in shielding the epithelial lining from acidic gastric juices and creating a neutral microenvironment. Parietal cells: Location in the gastric glands, predominantly in the fundus and body. Secretion of hydrochloric acid (HCl) for digestion and defense. Production of intrinsic factor and vitamin B12 absorption. Chief cells: Secretion of pepsinogen, converted to pepsin for protein digestion. Production of gastric lipase for lipid digestion. Enteroendocrine cells: Hormone secretion. Gastrin, acid secretion and gastric motility. 4. Protection and Functionality of Gastric Mucosa Physical and chemical barriers. Acidic environment maintained by parietal cells for enzymatic activity and pathogen defense. Coordination of cell functions for efficient digestion and protection. 5. Transition from Stomach to Small Intestine Anatomical junction marked by the pyloric sphincter. Balancing the acidic environment of the stomach with the intestinal conditions. Differences between stomach and intestinal epithelial barriers. 6. Microbial Communities in the Stomach and Intestines Limited microbial diversity in the stomach due to its low pH. Acid-resistant populations such as H. pylori and their impact on microbial diversity. H. pylori , chronic gastritis, ulcers, and gastric lining atrophy. 7. H. Pylori Infection and Symptoms Symptoms, manifestations. 8. Low Stomach Acid (Hypochlorhydria) The role of stress, aging, and infections. Downstream effects, particularly in the development of small intestinal bacterial overgrowth (SIBO). 9. Small Intestinal Bacterial Overgrowth (SIBO) Definition and microbial population thresholds. Protective mechanisms regulating bacterial density in the small intestine. Role of low stomach acid in bacterial colonization and overgrowth. Consequences of SIBO, including symptoms and metabolic activity of overgrown bacteria. 10. Conclusion Root cause analysis. Thank you to our episode sponsor: 1. Check out ⁠⁠Ulyana Organics'⁠⁠ ⁠⁠Tallow Wild Yam Cream⁠⁠ and ⁠⁠Healing Facial Oil⁠⁠, and use code ⁠⁠CHLOE10⁠⁠ 10% off your order. Thanks for tuning in! Get Chloe's Book Today! "⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠75 Gut-Healing Strategies & Biohacks⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠" Follow Chloe on Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@synthesisofwellness⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Follow Chloe on TikTok @chloe_c_porter Visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠synthesisofwellness.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to purchase products, subscribe to our mailing list, and more!

CME credits: 1.25 Valid until: 30-12-2025 Claim your CME credit at https://reachmd.com/programs/cme/biomarker-directed-approaches-for-frontline-treatment-of-advanced-gastricgej-cancers-the-evidence/29846/ The NCCN Clinical Practice Guidelines are crucial tool in the treatment of cancer and provide detailed recommendations for treatment selection. The guidelines are regularly updated as new therapies are approved or as drugs received expanded indications. Moreover, data are constantly evolving regarding the role of biomarkers and treatment choice. This activity has been designed to provide an overview of the NCCN guidelines for gastric, colorectal, and hepatocellular cancers and the optimal application of these recommendations to clinical practice.

CME credits: 1.25 Valid until: 30-12-2025 Claim your CME credit at https://reachmd.com/programs/cme/the-role-of-biomarker-driven-therapies-in-the-second-line-treatment-of-advanced-gastricgej-cancers-what-do-the-data-say/29847/ The NCCN Clinical Practice Guidelines are crucial tool in the treatment of cancer and provide detailed recommendations for treatment selection. The guidelines are regularly updated as new therapies are approved or as drugs received expanded indications. Moreover, data are constantly evolving regarding the role of biomarkers and treatment choice. This activity has been designed to provide an overview of the NCCN guidelines for gastric, colorectal, and hepatocellular cancers and the optimal application of these recommendations to clinical practice.

In this Q&A-packed episode of the Pound of Cure Weight Loss podcast, Dr. Weiner and Zoe answer listener questions about navigating post-surgery challenges like dumping syndrome, food noise, and pregnancy after weight loss surgery. Here are the highlights:How to Lower Your Set Point Without Food Noise Sabotaging YouListener Rain asked about dealing with chocolate cravings after losing just five pounds. The team shared practical tips:Balanced Meals: Avoid skipping meals and eat nutrient-dense foods like vegetables, lean proteins, and fiber.Curb Sugar Cravings: Plan indulgences and make healthy swaps, such as Greek yogurt with cocoa powder and banana.When to Consider Medications: GLP-1 medications like Wegovy or Zepbound may help reduce food noise for sustained weight loss.Considering Gastric Bypass Revision SurgeryPriscilla asked about revising her sleeve gastrectomy to address severe reflux and weight regain. Dr. Weiner outlined key points:Improved Safety: Advances in surgical techniques make bypass surgery much safer today.Risks: Be mindful of dumping syndrome, ulcers, and iron deficiency, which require diligent management.Benefits: Revision can alleviate reflux and improve long-term health outcomes. Mindful eating is essential for post-revision success.What is Dumping Syndrome?Dr. Weiner explained that dumping syndrome, common after bypass surgery, occurs when sugary or fatty foods enter the small intestine too quickly. To manage it:Prioritize lean proteins and vegetables.Avoid large meals and overly processed foods.Practice mindful eating to control portions and prevent discomfort.Should You Avoid Drinking After Eating?A listener wondered whether post-op patients must separate eating and drinking. Dr. Weiner dispelled the myth:No Universal Rule: The stomach pouch empties quickly, and drinking doesn't affect fullness.Listen to Your Body: Some may feel bloated when drinking with meals, so adjust based on personal comfort.Pregnancy After Weight Loss SurgeryAmanda sought advice on preparing for pregnancy post-surgery. Key recommendations included:Vitamin Adjustments: Switch to prenatal vitamins to ensure proper iron and folate levels while avoiding vitamin A toxicity.Mindful Nutrition: Focus on protein-rich, well-balanced meals while avoiding excessive weight gain.Manage Risks: Pregnancy slightly increases the chance of bowel obstruction, but with a proactive care team, this can be managed effectively.Key TakeawaysThis episode provides actionable advice for navigating challenges like dumping syndrome, food noise, and post-op pregnancy:Manage food noise with balanced meals, planned indulgences, or GLP-1 medications if necessary.Gastric bypass revision surgery can resolve reflux but requires careful post-op management.Dumping syndrome is manageable with mindful dietary adjustments.Pregnancy after surgery is safe and healthier with proper preparation and care.Join the ConversationSubmit your questions for future episodes and let Dr. Weiner and Zoe guide you with science-backed strategies for success after weight loss surgery.

TakeawaysCarnivore Ernährung wird als therapeutisches Werkzeug betrachtet.Fleisch hat eine zentrale Rolle in der menschlichen Evolution gespielt.Morphologische Anpassungen des Menschen unterstützen eine fleischbasierte Ernährung.Die Nährstoffdichte in tierischen Lebensmitteln ist höher als in pflanzlichen.Es gibt keine dokumentierten veganen Jägersammlergesellschaften.Gesättigte Fette sind in ihrer natürlichen Matrix unbedenklich.Die Inuit und andere Jägersammlergesellschaften zeigen, dass eine fleischlastige Ernährung gesund sein kann.Evidenzbasierte Ansätze sind entscheidend für die Ernährung.Kapitel00:00 - Einleitung: Ist carnivore Ernährung wirklich Unsinn? 01:00 - Fleisch und Evolution: Die Rolle der Steinwerkzeuge 02:50 - Australopithecus: Erste Hinweise auf Fleischkonsum 04:20 - Eiszeit und große Jäger: Homo erectus und die Megafauna 06:30 - Übergang zur Sesshaftigkeit: Ein langsamer Prozess 09:00 - Unsere Anatomie: Zähne, Magen und Verdauungstrakt 11:30 - Nährstoffe aus tierischer Nahrung: Hohe Dichte und Bioverfügbarkeit 13:50 - Antioxidantien, Ketose und entzündungsarme Ernährung 16:10 - Fehlende große Studien? Evidenz aus Fallstudien und Evolution 18:30 - Fazit: Fleisch als zentrales Nahrungsmittel der Menschheit Original Artikel: Iss Dich Gesund / 01-2025/ Seite 79 "Riedls Aufreger"Literaturquellen:Heinzelin, Jean de, et al. "Environment and behavior of 2.5-million-year-old Bouri hominids." Science 284.5414 (1999): 625-629.Richards, Michael P., and Erik Trinkaus. "Isotopic evidence for the diets of European Neanderthals and early modern humans." Proceedings of the National Academy of Sciences 106.38 (2009): 16034-16039.Mann, Neil. "Meat in the human diet: An anthropological perspective." Nutrition & Dietetics 64 (2007): S102-S107.Fujimori, Shunji. "Gastric acid level of humans must decrease in the future."World Journal of Gastroenterology 26.43 (2020): 6706Blumenschine, Robert J., et al. "Characteristics of an early hominid scavenging niche [and comments and reply]." Current anthropology 28.4 (1987): 383-407.Aiello, Leslie C., and Peter Wheeler. "The expensive-tissue hypothesis: the brain and the digestive system in human and primate evolution." Current anthropology (1995): 199-221.Gurven, Michael, and Hillard Kaplan. "Longevity among hunter‐gatherers: a cross‐cultural examination." Population and Development review 33.2 (2007): 321-365.Cordain, Loren, et al. "Plant-animal subsistence ratios and macronutrient energy estimations in worldwide hunter-gatherer diets." The American journal of clinical nutrition 71.3 (2000): 682-692.Lescinsky, Haley, et al. "Health effects associated with consumption of unprocessed red meat: a Burden of Proof study." Nature Medicine 28.10 (2022): 2075-2082.Astrup, Arne, et al. "Saturated fats and health: a reassessment and proposal for food-based recommendations: JACC state-of-the-art review." Journal of the American College of Cardiology 76.7 (2020): 844-857.Yamada, Satoru, et al. "Saturated Fat Restriction for Cardiovascular Disease Prevention: Systematic Review and Meta-Analysis of Randomized Controlled Trials." (2024).Beasley, DeAnna E., et al. "The evolution of stomach acidity and its relevance to the human microbiome." PloS one 10.7 (2015): e0134116.Norwitz, Nicholas G., and Adrian Soto-Mota. "Case report: Carnivore–ketogenic diet for the treatment of inflammatory bowel disease: a case series of 10 patients." Frontiers in Nutrition 11 (2024): 1467475.Calabrese, Lori, Rachel Frase, and Mariam Ghaloo. "Complete remission of depression and anxiety using a ketogenic diet: case series." Frontiers in Nutrition 11 (2024): 1396685.Cordain, Loren, et al. "The paradoxical nature of hunter-gatherer diets: meat-based, yet non-atherogenic." European journal of clinical nutrition 56.1 (2002): S42-S52.Beal, Ty, and Flaminia Ortenzi. "Priority micronutrient density in foods." Frontiers in nutrition 9 (2022): 806566.Ben‐Dor, Miki, Raphael Sirtoli, and Ran Barkai. "The evolution of the human trophic level during the Pleistocene." American journal of physical anthropology 175 (2021): 27-56. Bitte beachte auch immer den aktuellen "Haftungsausschluss (Disclaimer) und allgemeiner Hinweis zu medizinischen Themen" auf meiner Webseite.

Speaking of SurgOnc has a new home! New episodes can now be found under the Society of Surgical Oncology's podcast, SurgOnc Today, available on all major podcast platforms. Subscribe today to receive updates on new episode releases.  In this new episode of Speaking of SurgOnc, Dr. Rick Greene discusses with Dr. Michael Bouvet and Dr. Kristin Cox the applicability of M5A-IR800 to target human gastric cancer, as reported in their article, "Targeting Patient-Derived Orthotopic Gastric Cancers with a Fluorescent Humanized Anti-CEA Antibody."

Speaking of SurgOnc has a new home! New episodes can now be found under the Society of Surgical Oncology's podcast, SurgOnc Today, available on all major podcast platforms. Subscribe today to receive updates on new episode releases.  In this new episode of Speaking of SurgOnc, Dr. Rick Greene discusses with Dr. Michael Bouvet and Dr. Kristin Cox the applicability of M5A-IR800 to target human gastric cancer, as reported in their article, "Targeting Patient-Derived Orthotopic Gastric Cancers with a Fluorescent Humanized Anti-CEA Antibody."

Send us a textTake a listen to learn everything there is to know about this less common GI diagnosis- GAVE! Written by Dr. Zuhal Mohmand (Internal Medicine resident) and reviewed by Dr. Elizabeth Squirell (Gastroenterologist), Dr. Michelle Ricci (Gastroenterologist) and Dr. Heather Johnson (General Internal Medicine). Infographic by Sapriya Birk (Medical Student). Support the show

This week's froggy friend couldn't eat another bite.---Follow us on Tumblr! - https://weeklyfrogpod.tumblr.com/Follow us on Bluesky! - https://bsky.app/profile/weeklyfrogpod.bsky.socialCheck out our website! - https://frogpod.online/Check out The Worst Garbage! - https://theworstgarbage.online/---Thank you Boqeh for the music! Check him out! - https://boqeh.bandcamp.com/ 

Sometimes all of us have pains all over our bodies and don't understand why. Did you know what kind of pain is associated with each body organ? However, note that this information is of an introductory kind and shouldn't be taken as a strict guide. TIMESTAMPS Heart 0:36 Kidneys 1:00 Small intestine 1:21 Large intestine 1:37 Lungs 1:51 Appendix 2:13 Stomach 2:37 Gallbladder and liver 3:04 Pancreas 3:26 SUMMARY If something is wrong with the heart, a person feels compressing pain in the chest that can spread to the left arm, shoulder blade, and part of the neck.  Kidney pain can sometimes be confused with a simple backache. The difference is that kidney pain is deeper under the ribs, while muscle pain is usually lower. Problems with the small intestine usually cause pain in the navel region. If the pain persists and causes discomfort when bending or walking, don't put off a visit to a doctor. Issues with the large intestine are usually associated with pain in the lower abdomen, closer to the right side.  The lungs themselves don't feel pain due to a lack of nerve endings. But if something's wrong with them, you may feel a dull ache in your chest. The appendix is located in the lower right region of the abdomen, but pain may affect the whole stomach area or its separate parts. The pain may also travel to your right thigh. Other signs of issues with the appendix are nausea, vomiting, fever, and constipation or diarrhea. Gastric problems cause pain in the middle abdominal region above the ribs and can also appear on the same level in the back. Gallbladder and liver problems may cause pain in the upper right region of the abdomen. It can also travel to the same place in the back. Liver issues are also associated with a wide range of symptoms, such as a sour taste in the mouth and jaundice. Pancreatic problems are indicated by pain in the middle part of the upper abdominal region. However, a less intense pain may also travel to the whole stomach. Don't forget to hit the like button below the video, share it with others, and click subscribe to join the Bright Side of life! Subscribe to Bright Side: https://goo.gl/rQTJZz ---------------------------------------------------------------------------------------- Our Social Media: Facebook:   / brightside   Instagram:   / brightgram   5-Minute Crafts Youtube: https://www.goo.gl/8JVmuC  ---------------------------------------------------------------------------------------- For more videos and articles visit: http://www.brightside.me/ Learn more about your ad choices. Visit megaphone.fm/adchoices

On October 18, 2024, the FDA approved zolbetuximab plus fluoropyrimidine- and platinum-containing chemotherapy for the frontline treatment of adult patients with locally advanced unresectable or metastatic, HER2-negative, CLDN18.2-positive gastric or GEJ adenocarcinoma. This regulatory decision was backed by findings from the phase 3 SPOTLIGHT (NCT03504397) and GLOW (NCT03653507) trials. In SPOTLIGHT, In SPOTLIGHT, patients who received zolbetuximab plus mFOLFOX6 (5-fluorouracil, leucovorin, and oxaliplatin) achieved a median progression-free survival (PFS) of 10.6 months (95% CI, 8.9-12.5) vs 8.7 months (95% CI, 8.2-10.3) in those who received placebo plus chemotherapy (HR, 0.750; 95% CI, 0.601-0.936; 1-sided P = .0053). In GLOW, zolbetuximab plus CAPOX (capecitabine and oxaliplatin) generated a median PFS of 8.2 months (95% CI, 7.5-8.8) vs 6.8 months (95% CI, 6.1-8.1) with placebo plus CAPOX (HR, 0.771; 95% CI, 0.615-0.965; 1-sided P = .0118). In our exclusive interview, Dr Ajani discussed key considerations for the clinical use of zolbetuximab, including its anticipated adverse effect profile and the introduction of CLDN18.2 as a biomarker for assessment prior to treatment initiation.

The addition of preoperative chemoradiation therapy to perioperative chemotherapy did not improve overall survival as compared with perioperative chemotherapy alone in patients with resectable gastric or gastroesophageal junction adenocarcinomas. The multi-continent, Phase III randomized TOPGEAR trial has definitively found no benefit from adding radiation before surgery in terms of overall or progression-free survival. This clear finding was reported simultaneously in the New England Journal of Medicine and at the ESMO 2024 Congress held in Barcelona, Spain. After presenting the findings , first author Trevor Leong, MD, Radiation Oncologist at the Peter McCallum Cancer Centre in Melbourne, Australia, met up with Oncology Times reporter Peter Goodwin.

See omnystudio.com/listener for privacy information.

Take Home Points Orogastric lavage may still play an important role in treatment of the overdose patient.  Do not perform lavage if the ingestion has limited toxicity at any dose or the ingested dose is unlikely to cause significant toxicity. Strongly consider orogastric lavage in a patient who has taken an overdose of drugs that ... Read more The post REBEL Core Cast 129.0 – Gastric Lavage appeared first on REBEL EM - Emergency Medicine Blog.

In this episode, we review the high-yield topic of⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Gastric Polyps ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠from the Gastrointestinal section. Follow ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media: Facebook: www.facebook.com/medbullets Instagram: www.instagram.com/medbulletsofficial Twitter: www.twitter.com/medbullets

CME credits: 1.00 Valid until: 04-10-2025 Claim your CME credit at https://reachmd.com/programs/cme/bringing-treatment-into-focus-biomarker-driven-first-line-therapy-for-metastatic-gastricgej-cancers/26719/ This educational activity delves into biomarker-driven strategies for first-line therapy in metastatic gastric and gastroesophageal junction (GEJ) cancers. Participants will explore the latest clinical trial data and emerging biomarkers that guide treatment decisions. Our experts emphasize selecting optimal therapies tailored to patient-specific factors and offer strategies for managing treatment-related adverse effects. Tune in to enhance treatment efficacy and patient outcomes for your patients with metastatic gastric/GEJ cancers.=

Dr Philip Smith, Digital and Education Editor of Gut and Honorary Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Mario Dinis-Ribeiro from the Department of Gastroenterology at Porto Comprehensive Cancer Center & RISE—Health Research Network, Porto, Portugal, on the paper "The road to a world-unified approach to the management of patients with gastric intestinal metaplasia: a review of current guidelines" published in paper copy in Gut in October 2024. Please subscribe to the Gut podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3UOTwqS) or Spotify (https://spoti.fi/3Ifxq9p).

Gastric cancer is a leading cause of cancer death globally. Chronic H pylori infection is the primary cause of gastric cancer, responsible for at least 80% of the new cases. Constanza Camargo, PhD, of the National Cancer Institute joins JAMA Associate Editor John M. Inadomi, MD, to discuss co-testing with FIT and H pylori stool antigen to help prevent gastric cancer. Related Content: Fecal Immunochemical Test and Helicobacter pylori Stool Antigen Co-Testing Screening for Helicobacter pylori to Prevent Gastric Cancer

Today we will be talking about gastric and oesophageal cancer and what we have learnt about it as a community.This podcast is sponsored by the Pancare Foundation and funded by the Australian Government. The Pancare Foundation provides support to people impacted by a diagnosis of upper gastro intestinal cancer. The views expressed in this podcast do not necessarily represent the views of the Pancare Foundation.My special guests are Melanie Regan and Sue Hegarty, two cancer nurses with many decades of experience.

Christine Brezden-Masley, MD, PhD, FRCPC - Breaking Barriers: Expert Guidance on Best Strategies for Biomarker Testing in Gastric and GEJ Cancers

Diana N. Ionescu, MD - Pathological Assessment of HER2 Status in Gastric and Gastroesophageal Cancers: Important Steps That Can Impact Outcomes

Diana N. Ionescu, MD - Pathological Assessment of HER2 Status in Gastric and Gastroesophageal Cancers: Important Steps That Can Impact Outcomes

Mind Pump Fit Tip: The one MUST-DO hack to getting lean & healthy if you're starting at 30% body fat. (1:46) Moments when you get tested as a parent. (10:41) Earn phase of your life vs learn phase. (25:50) BPC-157 is crazy! (31:50) Fun Facts with Justin: Anal breathing. (37:47) The only ‘off the rack' suit for “jacked” guys! (40:10) A Pampers commercial is waiting to happen. (41:59) Fall is here, get your Vuori down jacket. (43:50) How CRAZY counterintelligence is getting! (45:16) The secret sauce is NOT baby oil. (49:15) At what point do we not respect authority? (55:29) Shout out to Mind Pump Show ‘mash-ups'. (1:00:27) #ListenerLive question #1 – What do you think about "resetting" each rep during a workout? (1:02:15) #ListenerLive question #2 – What's the best way to regain this muscle post-500-mile hike? (1:13:17) #ListenerLive question #3 – Should I stay in maintenance, do a bit of a bulk, or do a bit of a cut, and for how long if I want to get leaner? (1:23:40) Related Links/Products Mentioned Ask a question to Mind Pump, live! Email: live@mindpumpmedia.com Visit State & Liberty for an exclusive offer for Mind Pump listeners! ** Discount is now automatically applied at checkout 15% off your first order! ** Visit Vuori Clothing for an exclusive offer for Mind Pump listeners! ** No code to receive 20% off your first order. ** For Mind Pump listeners only, join IHP and Equi.Life for 2 full days of live exhibitions, inspiring keynote discussions, and engaging expert panels at The Reimagining Health Summit October 23 - October 25th in Orlando, FL. Visit here and use the code “LIVE100” which will give $100 off any level ticket (excluding virtual). September Promotion: MAPS Starter | Starter Bundle 50% off! ** Code SEPTEMBER50 at checkout ** Mind Pump #1937: How to Avoid Gaining Weight During the Holiday Season The 360 Degree Leader: Developing Your Influence from Anywhere in the Organization – Book by John C. Maxwell Mind Pump #2125: Heal Like Wolverine: BPC 157 with Dr. William Seeds TRANSCEND your goals! Telehealth Provider • Physician Directed GET YOUR PERSONALIZED TREATMENT PLAN! Hormone Replacement Therapy, Cognitive Function, Sleep & Fatigue, Athletic Performance and MORE. Their online process and medical experts make it simple to find out what's right for you. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth Scientists win Ig Nobel for discovering anal breathing in mammals What we know about the Hezbollah device explosions Watch Masters of the Air - Show - Apple TV+ Mind Pump Show - YouTube Visit Butcher Box for this month's exclusive Mind Pump offer!  ** Choose which high-quality, lean protein you'll get for free in every order for a year—wild-caught salmon, organic chicken breasts, or grass-fed ground beef. Plus, get $20 off your first order with our code. That's up to $404 in savings for the year! ** Mind Pump #2122: Deadlift Masterclass How To Sumo Deadlift (The RIGHT Way) | Jordan Syatt – Mind Pump TV What Is The Prerequisite For The Deadlift? – Dr. Jordan Shallow How To Hip Hinge Properly (Fix THIS!) Building Muscle with Adam Schafer – Mind Pump TV Mind Pump #2287: Bodybuilding 101- How to Bulk and Cut Mind Pump Podcast – YouTube Mind Pump Free Resources People Mentioned Dr. William Seeds (@williamseedsmd) Instagram  

Syed's chaotic confrontation style • Gastric panic in Mexico • Dealing with a gasoline spill that found it's way into the house • Leaving a review for your proctologist • Raccoon disposal

Did you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.

Links to Resources Mentioned:Explore our How to Ditch Cravings & Overeating Masterclass & other mini courses here: https://www.breakingthroughwellness.com/storeSave 20% on Kion Essential Aminos, Clean Protein, Colostrum & more: https://www.getkion.com/pages/maximizingVisit https://www.breakingthroughwellness.com/ for a free nutrition guide, to book a FREE 30-MINUTE CONSULT & learn about our industry-leading 1:1 coaching program & results for active women age 35 & beyond.Episode 20: My Epic Career Journey & How I Turned My Health, Hormone, Fitness & Running Breakdowns Into Breakthroughs: https://podcasts.apple.com/us/podcast/maximizing-fitness-physique-running-through-perimenopause/id1716725195?i=1000649161954Episode 15: 3 Simple Steps to Overcome Feeling Blah, Anxious & Depressed: https://podcasts.apple.com/us/podcast/maximizing-fitness-physique-running-through-perimenopause/id1716725195?i=1000644609076Curious about how rapid weight loss might be affecting your muscle and bone health? In this episode, Louise dives into the risks associated with popular GLP-1 medications like Ozempic, particularly for active women and runners going through perimenopause. Drawing from her 21 years of clinical experience, Louise—a leading expert for perimenopausal active women and runners—breaks down the myths and uncovers the truth about how, in certain contexts, weight loss medications and surgeries can do more harm than good. In fact, there are many unexpected consequences for active women and runners that even the medical community never saw coming! Louise doesn't just talk the talk; she also shares her personal struggles with hormonal imbalances, emotional eating, and how she's navigated these challenges. You'll gain practical tips on overcoming late-night cravings, the importance of community support, and how to maintain healthy habits as your body changes.This episode is a must-listen for any woman navigating perimenopause, fitness enthusiasts, or anyone who wants to stay healthy as they age. You'll leave with a clearer understanding of your body and practical steps to enhance your wellness journey.Episode Highlights:(7:04) The impact of gastric sleeve surgery on fitness and nutrition(8:19) The risks associated with GLP-1 medications like Ozempic(10:28) Exercise effectiveness while on weight loss medications(16:29) Practical nutrition strategies for women post-surgery(24:36) Addressing overeating habits and their hormonal roots(28:36) Personal story: Overcoming emotional eating triggers.(36:26) Strategies for maintaining health and fitness in high-stress situations(45:21) OutroTune in weekly to "Maximizing Fitness, Physique, and Running Through Perimenopause" for a simple female-specific science-based revolution. Let's unlock our best with less stress!I'd love to connect!Instagram

With such a high prevalence, particularly in performance horses, understanding the causes, risk factors, diagnostics, treatments and preventive approaches to Equine Gastric Ulcer Syndrome is key for both riders and veterinarians. Join us as board-certified equine veterinary internal medicine specialist, Dr. Amy Polkes, takes us deep into ulcers and how she and fellow veterinarians tackle this challenge on the daily.

Dr. Jeanine Cook-Garard learns about the growing popularity of weight loss drugs like Ozempic, weight loss surgical options, and what other options you might have to lose weight if you are dangerously overweight. She speaks with Dr. Charles E. Thompson, an Advanced Robotic and Bariatric Surgeon who is the Associate Program Director of the Mount Sinai South Nassau General Surgery Residency Program, and an Assistant Professor of Surgery at the Mount Sinai Icahn School of Medicine.

Last week we talked about the nutrients many people are deficient in. Today, we talk about WHY. This is where we dig into the processes in the body that lead to proper nourishment, and those that can hamper them. When we understand why, we can then make a plan for better nutrition and reduce the need for supplementation. Of this list, there are three I want to dig into in more detail, and one of them I cover today - proper production and release of gastric juices. What are they? Where do they come from? What do they contain? What happens when they are not functioning correctly, and how can we balance them? All of this answered in today's podcast! This episode is included in either the Community Herbalism or Clinical Herbalism program, offered by Herba Remedium. Herba Remedium is an online, Christian herbalist school. These programs are currently in development, but you can currently enroll in The Family Herbalism Course, or get on the waitlist for one of these new offerings. For more information visit www.herbaremedium.com or email laureltreewellness@gmail.com.For more information about Laurel Tree Wellness, your host Naomi Kilbreth, or herbal consultations to help you create a wellness plan, visit www.laureltreewellnessllc.com.

Check out these 15 symptoms of high blood sugar that might occur while you're sleeping. 1. Frequent urinating This is known as nocturia and occurs when your kidneys remove excess sugar from your blood. 2. Excessive thirst As your kidneys eliminate sugar through your urine, you deplete magnesium, potassium, and calcium. You can also become dehydrated, so you may have excessive thirst. 3. Restless legs syndrome Excess sugar depletes vitamin B1. Vitamin B1 deficiency causes lactic acid buildup and a lack of oxygen in the legs. This can also be related to magnesium deficiency. 4. Peripheral neuropathy This condition causes burning, pain, or numbness on the bottom of the feet. Benfotiamine combined with alpha lipoic acid is a great remedy. 5. Cramps in lower legs and feet Too much sugar in the blood can cause a magnesium deficiency and calcium buildup. Magnesium glycinate supplements can help, and can also improve sleep. 6. Excessive sweating This usually occurs in the face, neck, or upper part of the body. High blood sugar causes sympathetic dominance, which causes a person to be in a constant state of fight or flight. 7. Sleep apnea This usually occurs because a person has high levels of insulin. 8. Hypoglycemia If you have high blood sugar, your body will try to lower it with insulin. This can cause you to wake up during the night with low blood sugar. Following a low-carb diet for at least 6 to 8 months can help correct this problem. 9. Delayed sleep High levels of sugar delay the release of melatonin. 10. Gastric reflux High blood sugar can affect the autonomic nervous system that controls the valve on the top of the stomach, causing GERD. 11. Nightmares/vivid dreams This is typically related to a neurotransmitter problem caused by a deficiency in vitamin B1, which is depleted by high blood sugar. 12. High blood pressure Nocturnal dipping occurs when your blood pressure and pulse rate decrease during sleep. When you have diabetes, this doesn't happen. This is called non-dipping. 13. Heart palpitations This is caused by a lack of potassium and magnesium and can be corrected with a good electrolyte powder. 14. Teeth grinding The activation of the sympathetic nervous system puts a person into a state of stress while they're sleeping, causing teeth grinding. 15. Headache upon waking This usually occurs because of dehydration.

The "Feed Room Chemist" joined us in this episode of "Pivot Point of View" where we talk about all things equine nutrition. Dr. Jyme Nichols of Blue Bonnet Feeds provides an in depth look into equine nutrition and provides insight for managing different behaviors that can be caused by holes in your nutrition program that lead to things like gastric and hind gut ulcers. You can learn more about what Dr. Jyme and her team can do at www.bluebonnetfeeds.com or listen to her podcast "Feed Room Chemist" for more in depth discussions on equine nutrition.

Joe Ferra, CEO of Elevation Oncology, highlights the unmet needs in gastric cancer and the potential of targeting Claudins, proteins involved in cell adhesion. The current competitive landscape of antibody drug conjugates (ADCs) confirms the promise of a targeted therapy that delivers a cytotoxic drug directly to cancer cells. Targeting Claudin 18.2 with an ADC approach offers an opportunity to treat a broader range of tumors expressing a lower level of Claudin 18.2 than those currently treated by CAR-T therapy. This approach is being investigated as a single-agent drug with promise for use in combination for gastric cancer, pancreatic cancer and esophageal cancer. Joe explains, "As you likely know, in the continuum of cancer drugs, you have chemotherapy on one end that indiscriminately kills everything it touches. On the other end, you have uber-targeted therapies looking at specific drivers of what's driving that specific tumor. In our case at Elevation Oncology, we're focused on what we like to call selected targeted oncology drugs so that we are using the unique characteristics of the tumor to target and meet in a targeted way attempt to kill the tumor for a better outcome for the patient." "Gastric cancer in and of itself was an area where Claudin 18.2 is known to be highly expressed, but for gastric cancer, to your point, there's a huge unmet need. For most patients, once they're in second line or third line, the opportunity for drugs that are available to them today is, unfortunately for all of us, very dismal. We think there's a significant opportunity to utilize a Claudin 18.2 antibiotic drug conjugate for overall better outcomes for patients living with gastric cancer." "We quickly saw an ADC approach as an opportunity to treat a broader range of Claudin 18.2 expression. Now, as I'm sure you're aware, in any target in any tumor, there's always a range of expression for Claudin 18.2. In gastric cancer, it's known that as much as 80% of gastric cancer expressed Claudin 18.2 at some level. With that expression, we think an ADC approach will be able to treat a broader range of expression." #ElevationOncology #ADC #AntibodyDrugConjugate #SolidTumors #Claudin182 #Claudins #Cancer ElevationOncology.com Download the transcript here 

Joe Ferra, CEO of Elevation Oncology, highlights the unmet needs in gastric cancer and the potential of targeting Claudins, proteins involved in cell adhesion. The current competitive landscape of antibody drug conjugates (ADCs) confirms the promise of a targeted therapy that delivers a cytotoxic drug directly to cancer cells. Targeting Claudin 18.2 with an ADC approach offers an opportunity to treat a broader range of tumors expressing a lower level of Claudin 18.2 than those currently treated by CAR-T therapy. This approach is being investigated as a single-agent drug with promise for use in combination for gastric cancer, pancreatic cancer and esophageal cancer. Joe explains, "As you likely know, in the continuum of cancer drugs, you have chemotherapy on one end that indiscriminately kills everything it touches. On the other end, you have uber-targeted therapies looking at specific drivers of what's driving that specific tumor. In our case at Elevation Oncology, we're focused on what we like to call selected targeted oncology drugs so that we are using the unique characteristics of the tumor to target and meet in a targeted way attempt to kill the tumor for a better outcome for the patient." "Gastric cancer in and of itself was an area where Claudin 18.2 is known to be highly expressed, but for gastric cancer, to your point, there's a huge unmet need. For most patients, once they're in second line or third line, the opportunity for drugs that are available to them today is, unfortunately for all of us, very dismal. We think there's a significant opportunity to utilize a Claudin 18.2 antibiotic drug conjugate for overall better outcomes for patients living with gastric cancer." "We quickly saw an ADC approach as an opportunity to treat a broader range of Claudin 18.2 expression. Now, as I'm sure you're aware, in any target in any tumor, there's always a range of expression for Claudin 18.2. In gastric cancer, it's known that as much as 80% of gastric cancer expressed Claudin 18.2 at some level. With that expression, we think an ADC approach will be able to treat a broader range of expression." #ElevationOncology #ADC #AntibodyDrugConjugate #SolidTumors #Claudin182 #Claudins #Cancer ElevationOncology.com Listen to the podcast here 

Gastric (stomach) and esophageal cancers are common malignancies that affect the first parts of the digestive tract. About 50,000 new cases of gastric and esophageal cancer will be diagnosed each year in the United States. In this episode of the All In Against Cancer podcast, gastrointestinal medical oncologist Dr. Jonathan Mizrahi talks with Ochsner surgical oncologist, Dr. Nathan Bolton, and surgical oncology nurse practitioner, Jessica Pride, to learn more about the diagnosis, staging and management of patients with gastroesophageal cancers.

Roger Seheult, MD of MedCram untangles common misconceptions and provides general information for treating GERD. See all Dr. Seheult's videos at: https://www.medcram.com/ (This video was recorded on June 30th, 2024) Roger Seheult, MD is the co-founder and lead professor at https://www.medcram.com He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine. MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS: MedCram offers group discounts for students and medical programs, hospitals, and other institutions. Contact us at customers@medcram.com if you are interested. MEDIA CONTACT: Media Contact: customers@medcram.com Media contact info: https://www.medcram.com/pages/media-contact Video Produced by Kyle Allred FOLLOW US ON SOCIAL MEDIA: https://www.facebook.com/MedCram https://twitter.com/MedCramVideos https://www.instagram.com/medcram DISCLAIMER: MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor. #gerd #acidreflux #gastrichealth

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/VTE865. CME/MOC/NCPD/AAPA credit will be available until July 2, 2025.Catalysts for Change in Gastric and GEJ Cancer: Digesting New Evidence and Future Directions of Care With Innovative Immunotherapy and Targeted Platforms In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Hope For Stomach Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through educational grants from Astellas, BeiGene, and Bristol Myers Squibb.Disclosure information is available at the beginning of the video presentation.

Today we discuss what patients need to know about gastric and oesophageal cancer. My special guests are Nick Verry, who shares his cancer journey, and Dr Ralph Audehm, a general practitioner.This podcast is sponsored by the Pancare Foundation.  With MJA news and online editor, Sam Hunt. 27 mins.

In the second part of a two-episode Horse & Hound Podcast promotional feature with Dengie, Horse & Hound's podcast host Pippa Roome chats to Samy Julliand, a researcher from Dijon, France who runs the Lab to Field research centre and has published a number of papers exploring different dietary approaches to feeding horses that help to reduce the risk of ulcers, plus Dr Katie Williams, technical and product development manager at Dengie, about equine glandular gastric disease, also known as EGGD, and the role alfalfa can play when managing horses with the condition.

Joseph is a 14 year-old, generally well and up-to-date with health maintenance, who presents for a sick with a 36 h hx of gradual onset nausea, vomiting and loose stools, reporting “I'm not sure how many times I threw up or had diarrhea.” He last vomited about 4 h ago, last stool was around 2 h ago, reported as yellow brown in color, small volume and without blood.  He has been tolerating a sips of clear liquids for the past 3 h and voided a small amount around 2 h ago. Joesph reports that he is on the wresting team at his high school and that, “For the past week, one guy after another got this same thing.” VS are within normal limits and his mucous membranes are slightly dry. The most likely cause of Joseph's clinical condition is: A. Staphylococcal food poisoningB. Clostridium difficile (C. diff) enteritisC. Viral gastroenteritisD. Gastric ulcer Visit fhea.com to learn more!